Form 8-K - Current report:
SEC Accession No. 0001140361-21-011095
Filing Date
2021-03-31
Accepted
2021-03-31 17:18:33
Documents
9
Period of Report
2021-03-25
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10022537_8k.htm 8-K 146176
2 EXHIBIT 3.1 brhc10022537_ex3-1.htm EX-3.1 8656
3 EXHIBIT 3.2 brhc10022537_ex3-2.htm EX-3.2 6878
4 EXHIBIT 3.3 brhc10022537_ex3-3.htm EX-3.3 6711
5 EXHIBIT 3.4 brhc10022537_ex3-4.htm EX-3.4 102822
6 EXHIBIT 10.1 brhc10022537_ex10-1.htm EX-10.1 37135
7 EXHIBIT 10.2 brhc10022537_ex10-2.htm EX-10.2 163113
8 EXHIBIT 10.3 brhc10022537_ex10-3.htm EX-10.3 10072
9 EXHIBIT 10.4 brhc10022537_ex10-4.htm EX-10.4 9687
  Complete submission text file 0001140361-21-011095.txt   493121
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 21794653
SIC: 2834 Pharmaceutical Preparations